Platelet-inspired medicine for tumor therapy

Jie Yang; Shujun Wang; Ping Liu; Lu Dai; Baoan Chen; Jianfeng Luan; Jiaying Zhou

doi:10.18632/oncotarget.22853

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Platelet-inspired medicine for tumor therapy

Jie Yang, Shujun Wang, Ping Liu, Lu Dai, Baoan Chen _, Jianfeng Luan and Jiaying Zhou

PDF | HTML | How to cite

Oncotarget. 2017; 8:115748-115753. https://doi.org/10.18632/oncotarget.22853

Metrics: PDF 1794 views | HTML 2840 views | ?

Abstract

Jie Yang1,*, Shujun Wang2,*, Ping Liu1, Lu Dai1,3, Baoan Chen1, Jianfeng Luan2 and Jiaying Zhou4

1Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China

2Department of Blood Transfusion, Nanjing General Hospital of PLA, Nanjing, People’s Republic of China

3Department of Bioengineering, University of California, Berkeley, CA, United States of America

4Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China

*These authors have contributed equally to this work

Correspondence to:

Baoan Chen, email: [email protected]

Keywords: platelet; tumor; drug-loaded system

Received: September 15, 2017 Accepted: November 13, 2017 Published: December 01, 2017

ABSTRACT

As the number of patients with tumor increases dramatically recent years, traditional therapies expose more and more problems which can even lead to death. Many researchers and clinicians quest for an efficient drug delivery system to deal with tumor as a result. With the researches further develop, we find that platelet can interact with tumor cells through a variety of ways. So it can be used as a carrier broadly to deliver different anti-tumor drugs for tumor treatment. In the present review, we summarize the interaction of tumor cells and platelet. At the same time, we focus on recent progress on the application of platelet drug-loaded system in the anti-tumor prospects.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22853

Publication Alerts

Reviews:

Platelet-inspired medicine for tumor therapy

Abstract